A randomized, open-label phase IIb study of maintenence therapy with a MUC-1 dendritic cell vaccine in patients with epithelial ovarian cancer in first or second remission.


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Gray, HJ; Secord, AA; Anderson, ML; DelPriore, G; Tchabo, NE; Berek, JS

Published Date

  • May 20, 2010

Published In

Volume / Issue

  • 28 / 15_suppl

Start / End Page

  • TPS171 - TPS171

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2010.28.15_suppl.tps171